CClinicalTrials.gg
RecruitingNCT06275321Updated Feb 23, 2024

Physical Exercise Benefits for Cancer Patients

An interventional study of Synchronous-supervised online home-based group and Exercise recommendation group in Cancer, Breast and Sports Physical Therapy, sponsored by Universitat Jaume I. Recruiting at 1 site in Spain. Open to female participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2024-02-23.

Sponsored by Universitat Jaume I · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Registered 2 years 2 months after the study started (first participant enrolled Nov 2021, registered Jan 2024).
  • Started Nov 2021; still recruiting 4 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
Female
01

Study summary

The purpose of the study was to analyze the effect of a synchronous-supervised online home-based group during a 6-month exercise program on physical fitness, body composition and adherence compared to an exercise recommendation group of patients undergoing breast cancer treatment without supervision.

02

Conditions studied

  • Cancer, Breast
  • Sports Physical Therapy

Browse trials for

Keywords

  • Oncology
  • Quality of live
  • Physical exercise
  • Physical activity
  • Physical fitness
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 60 is below the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Universitat Jaume I is the lead sponsor of 79 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • 18 years old or older
  • Diagnosted with breast cancer
  • Undergoing cancer treatment
  • No medical contraindications

Exclusion criteria

Exclusion Criteria:

  • Medical contraindications for sport practice
  • Refusal to participate in the study
  • Comorbilities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Synchronous-supervised online home-baased group

    Group following a supervised exercise program with an exercise cancer specialist

    Other: Synchronous-supervised online home-based group

  • Active comparator
    Exercise recommendation group

    Group following general recommendations of physical exercise

    Other: Exercise recommendation group

Interventions

  • OtherSynchronous-supervised online home-based group

    An online exercise program combining endurance and strength training

  • OtherExercise recommendation group

    General recommendation about physical exercise. No supervised

06

What researchers measure

Primary outcomes

  1. Cardiorrespiratory fitness

    6 minutes walking test was performed in a 50 meter circuit. Meters completed during 6 minutes were recorded.

    Time frame: 24 weeks

  2. Strength - Chair Stand (repetitions)

    Chair stand test was performed. Number of repetitions performed during 30 seconds was recorded.

    Time frame: 24 weeks

  3. Flexibility

    Sit and Reach (centimeters): sitted and with stretched legs, the patient has to move a piece of wood on a bench. The centimeters moved by the patients are recorded

    Time frame: 24 weeks

  4. Incidence of treatments on quality of live assessed by EORTIC QLQ-C30

    QLQ-C30 questionnaire with 30 items was used to record the quality of life of the patients. Each item has a scale from 1 to 4, being 1 the lowest and 4 the highest outcome.

    Time frame: 24 weeks

  5. Adherence

    Minutes on each training session were recorded to control the adherence.

    Time frame: 24 weeks

  6. Rating of perceived exertion

    A Borg Scale (1-10) was used to control the intensity of the sessions, being 1 the lowest intensity and 10 the highest intensity.

    Time frame: 24 weeks

  7. Strength - Hand Grip (Kilograms)

    Hand Grip (kilograms): a dynamometer (Grip Strength Dynamometer, Takker TKK, Tokio, Japón) was used to record hand grip.

    Time frame: 24 weeks

  8. Strength - Squat Jump (height in centimeters)

    Squat Jump (centimeters): a contact platform (Chronojump Boscosystem, Barcelona, Spain) was used to record the height of the jump in centimeters.

    Time frame: 24 weeks

07

Study locations

1 of 1 sites recruiting
  • Jaume I University
    Castellón De La Plana, Castellón 12071, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06275321
Lead sponsor
Universitat Jaume I
Responsible party
Elena Garcia Roca (Principal investigator, Universitat Jaume I) — Principal investigator
First posted
Feb 23, 2024
Start date
Nov 5, 2021
Primary completion
Jul 27, 2024 (estimated)
Completion
Jul 30, 2025 (estimated)
Last update
Feb 23, 2024

Study contacts

M. Elena Garcia-Roca, MSc
Contact
garciroc@uji.es
+34 629112367
Eladio J Collado-Boira, PhD
Contact
colladoe@uji.es
+34 606133368
M. Elena Garcia-Roca, MSc
principal investigator · Universitat Jaume I
Eladio J. Collado-Boira, PhD
study director · Universitat Jaume I

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion